WTA-24709-93364
3 vaccinations
5 coded responses
39 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 974 / OR
- Registered
- 2021-04-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-11
Registered in v-safe
-
2021-04-11
Dose 1 — Pfizer-BioNTech
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-19
- 2021-04-25
-
2021-05-02
Dose 2 — Pfizer-BioNTech
- 2021-05-02
- 2021-05-03
-
2021-05-04
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Swollen lymph node near collar bone, on the side of injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-04
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-05
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph node near dollar boneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-06
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph node in collar bone areaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-07
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph node near collar boneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-08
- 2021-05-09
- 2021-05-16
- 2021-05-23
- 2021-05-30
- 2021-06-06
- 2021-06-13
- 2021-08-01
- 2021-10-31
-
2021-12-30
Dose 3 — Pfizer-BioNTech
- 2021-12-31
-
2022-01-01
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2022-01-02
- 2022-01-03
- 2022-01-04
- 2022-01-05
- 2022-01-06
- 2022-01-13
- 2022-01-20
- 2022-01-27
- 2022-02-03
- 2022-02-10
- 2022-03-31
-
2022-05-06
Call successfulDoes not wish to fill out VAERS report
-
2022-06-30
Survey response — 6 months, dose 3MedDRA: Cough, Oropharyngeal pain, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cough, sore throat, congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-12-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-11 | Pfizer-BioNTech | |
| 2 | 2021-05-02 | Pfizer-BioNTech | |
| 3 | 2021-12-30 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-04 | Successful 2022-05-06 |
Does not wish to fill out VAERS report |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph node near collar bone, on the side of injection
Systemic reaction (other): Swollen lymph node near dollar bone
Systemic reaction (other): Swollen lymph node in collar bone area
Systemic reaction (other): Swollen lymph node near collar bone
Release 12 — 6 months, dose 3
Symptoms: Cough, sore throat, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release